HighVista Strategies’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,277
Closed -$235K 151
2023
Q3
$235K Buy
+10,277
New +$539K 0.11% 132
2022
Q4
Sell
-17,601
Closed -$498K 129
2022
Q3
$498K Sell
17,601
-11,629
-40% -$324K 0.28% 81
2022
Q2
$634K Buy
29,230
+18,313
+168% +$511K 0.38% 64
2022
Q1
$438K Sell
10,917
-12,834
-54% -$537K 0.28% 78
2021
Q4
$1.13M Buy
23,751
+3,406
+17% +$183K 0.9% 39
2021
Q3
$1.15M Buy
20,345
+2,428
+14% +$147K 0.76% 42
2021
Q2
$1.03M Buy
+17,917
New +$986K 0.73% 21

Other funds holding MORF

HighVista Strategies's MORF Position: Q4 2023 in Review

HighVista Strategies sold out of Morphic Holding, Inc. Common Stock (MORF) in Q4 2023, closing a stake of 10,277 shares — an estimated $235K sold.

HighVista Strategies first reported a position in MORF in Q2 2021 and held it in 7 quarters. The position peaked at $1.15M in Q3 2021. 135 funds tracked by Wall St. Rank hold MORF as of Q4 2023.

  • HighVista Strategies reported no remaining Morphic Holding, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • HighVista Strategies sold 10,277 Morphic Holding, Inc. Common Stock shares in Q4 2023, an estimated $235K.
  • HighVista Strategies first reported a position in Morphic Holding, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • HighVista Strategies's Morphic Holding, Inc. Common Stock position peaked at $1.15M in Q3 2021.
  • 135 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q4 2023.

Based on HighVista Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.